Concepts (238)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Confined Spaces | 1 | 2020 | 10 | 0.710 |
Why?
|
Lymphatic Metastasis | 5 | 2021 | 2882 | 0.620 |
Why?
|
Hematopoietic Stem Cells | 4 | 2022 | 3406 | 0.510 |
Why?
|
Longevity | 1 | 2022 | 1087 | 0.450 |
Why?
|
Mutation | 7 | 2024 | 30184 | 0.390 |
Why?
|
Lymph Nodes | 3 | 2021 | 3451 | 0.350 |
Why?
|
Hematopoiesis | 5 | 2022 | 2061 | 0.350 |
Why?
|
Genetic Heterogeneity | 3 | 2020 | 735 | 0.350 |
Why?
|
Telomerase | 1 | 2015 | 749 | 0.340 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4885 | 0.320 |
Why?
|
Colorectal Neoplasms | 3 | 2020 | 6952 | 0.320 |
Why?
|
Cell Proliferation | 9 | 2024 | 10428 | 0.320 |
Why?
|
Phylogeny | 4 | 2020 | 2836 | 0.320 |
Why?
|
Poly G | 2 | 2021 | 6 | 0.310 |
Why?
|
Atherosclerosis | 3 | 2021 | 3425 | 0.310 |
Why?
|
DNA, Neoplasm | 1 | 2014 | 1740 | 0.310 |
Why?
|
Colonic Neoplasms | 2 | 2023 | 2531 | 0.290 |
Why?
|
Aneuploidy | 2 | 2024 | 578 | 0.280 |
Why?
|
Macrophages | 5 | 2023 | 5772 | 0.280 |
Why?
|
Breast Neoplasms | 10 | 2024 | 21053 | 0.260 |
Why?
|
Myeloid Cells | 3 | 2021 | 839 | 0.250 |
Why?
|
Neoplasms | 7 | 2024 | 22345 | 0.230 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5787 | 0.220 |
Why?
|
Models, Biological | 5 | 2021 | 9441 | 0.210 |
Why?
|
Microsatellite Repeats | 2 | 2015 | 784 | 0.200 |
Why?
|
Myelopoiesis | 2 | 2020 | 135 | 0.190 |
Why?
|
Germ Layers | 1 | 2021 | 72 | 0.190 |
Why?
|
Osteopontin | 1 | 2023 | 304 | 0.190 |
Why?
|
Mosaicism | 1 | 2024 | 481 | 0.180 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2024 | 584 | 0.180 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3948 | 0.170 |
Why?
|
Guanine | 1 | 2021 | 282 | 0.170 |
Why?
|
Neoplasm Seeding | 1 | 2020 | 85 | 0.170 |
Why?
|
Acetylcholine | 1 | 2022 | 626 | 0.170 |
Why?
|
Biomass | 1 | 2020 | 136 | 0.170 |
Why?
|
Mice | 23 | 2023 | 81792 | 0.160 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 548 | 0.160 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5388 | 0.150 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2008 | 3606 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2020 | 498 | 0.140 |
Why?
|
Gene Expression Regulation, Neoplastic | 5 | 2020 | 8603 | 0.140 |
Why?
|
Osteosarcoma | 1 | 2023 | 909 | 0.140 |
Why?
|
Lymphatic Vessels | 1 | 2021 | 355 | 0.140 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13448 | 0.140 |
Why?
|
Animals | 25 | 2023 | 168731 | 0.140 |
Why?
|
Angiotensins | 1 | 2017 | 139 | 0.130 |
Why?
|
INDEL Mutation | 1 | 2017 | 268 | 0.130 |
Why?
|
Receptor, erbB-3 | 1 | 2017 | 141 | 0.130 |
Why?
|
Physical Conditioning, Animal | 1 | 2019 | 365 | 0.130 |
Why?
|
DNA | 2 | 2021 | 7200 | 0.130 |
Why?
|
Diastole | 1 | 2018 | 785 | 0.120 |
Why?
|
Maytansine | 1 | 2015 | 87 | 0.120 |
Why?
|
Apolipoproteins E | 1 | 2021 | 1458 | 0.120 |
Why?
|
Genetic Variation | 2 | 2020 | 6607 | 0.110 |
Why?
|
Embryonic Stem Cells | 1 | 2021 | 1242 | 0.110 |
Why?
|
Receptors, CCR2 | 1 | 2015 | 214 | 0.110 |
Why?
|
Gene Expression Profiling | 5 | 2023 | 9522 | 0.110 |
Why?
|
Sleep Deprivation | 1 | 2021 | 849 | 0.110 |
Why?
|
Humans | 33 | 2024 | 765734 | 0.110 |
Why?
|
Immunotherapy | 2 | 2020 | 4752 | 0.110 |
Why?
|
Mice, Inbred C57BL | 7 | 2021 | 22321 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1788 | 0.100 |
Why?
|
Cell Differentiation | 3 | 2021 | 11641 | 0.100 |
Why?
|
Brain Neoplasms | 3 | 2021 | 9071 | 0.100 |
Why?
|
Bone Marrow Cells | 1 | 2020 | 2412 | 0.100 |
Why?
|
Cell Lineage | 1 | 2021 | 2573 | 0.100 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2019 | 1061 | 0.100 |
Why?
|
Heart Conduction System | 1 | 2017 | 1006 | 0.090 |
Why?
|
Epigenomics | 2 | 2015 | 959 | 0.090 |
Why?
|
Liposarcoma | 1 | 2014 | 288 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2021 | 3584 | 0.090 |
Why?
|
Bone Marrow | 1 | 2021 | 2918 | 0.090 |
Why?
|
Disease Progression | 2 | 2020 | 13614 | 0.090 |
Why?
|
Leukocytosis | 2 | 2021 | 248 | 0.080 |
Why?
|
Monocytes | 2 | 2018 | 2594 | 0.080 |
Why?
|
Mitosis | 1 | 2014 | 1172 | 0.080 |
Why?
|
Doxorubicin | 2 | 2012 | 2229 | 0.080 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2011 | 614 | 0.080 |
Why?
|
Adenocarcinoma | 2 | 2017 | 6356 | 0.070 |
Why?
|
Lymphokines | 1 | 2011 | 911 | 0.070 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2015 | 949 | 0.070 |
Why?
|
Neoplasm Proteins | 2 | 2017 | 3593 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2015 | 3605 | 0.070 |
Why?
|
Glioblastoma | 1 | 2023 | 3459 | 0.070 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2017 | 2878 | 0.070 |
Why?
|
Disease Models, Animal | 3 | 2021 | 18289 | 0.070 |
Why?
|
Organ Specificity | 2 | 2024 | 1964 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4352 | 0.070 |
Why?
|
Mice, SCID | 3 | 2018 | 2627 | 0.070 |
Why?
|
Receptors, CXCR4 | 1 | 2011 | 728 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1758 | 0.060 |
Why?
|
Liver Regeneration | 1 | 2007 | 213 | 0.060 |
Why?
|
Receptor, erbB-2 | 1 | 2015 | 2592 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4763 | 0.060 |
Why?
|
Cell Line, Tumor | 6 | 2019 | 17062 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4417 | 0.060 |
Why?
|
Transforming Growth Factor beta | 1 | 2012 | 1994 | 0.060 |
Why?
|
Cohort Studies | 2 | 2020 | 41631 | 0.060 |
Why?
|
Aging | 2 | 2021 | 8730 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5188 | 0.060 |
Why?
|
Heart Atria | 2 | 2023 | 1363 | 0.060 |
Why?
|
Carrier Proteins | 1 | 2017 | 4912 | 0.050 |
Why?
|
RNA, Small Interfering | 3 | 2018 | 3419 | 0.050 |
Why?
|
Female | 17 | 2024 | 395961 | 0.050 |
Why?
|
gamma Catenin | 1 | 2023 | 45 | 0.050 |
Why?
|
Mice, Inbred NOD | 2 | 2018 | 1837 | 0.050 |
Why?
|
Melanoma | 1 | 2021 | 5690 | 0.050 |
Why?
|
Mice, Nude | 3 | 2015 | 3614 | 0.050 |
Why?
|
Neoplasm Staging | 1 | 2017 | 11201 | 0.050 |
Why?
|
Versicans | 1 | 2021 | 40 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2021 | 11504 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 3 | 2017 | 6499 | 0.050 |
Why?
|
Cholinergic Agents | 1 | 2022 | 97 | 0.050 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2011 | 2839 | 0.050 |
Why?
|
Losartan | 1 | 2023 | 263 | 0.050 |
Why?
|
Antineoplastic Agents | 4 | 2017 | 13639 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2017 | 59459 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2015 | 5781 | 0.040 |
Why?
|
Lymphatic System | 1 | 2021 | 250 | 0.040 |
Why?
|
Inflammation | 1 | 2019 | 10846 | 0.040 |
Why?
|
Prognosis | 2 | 2017 | 29899 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2024 | 752 | 0.040 |
Why?
|
Mice, Knockout | 3 | 2021 | 14445 | 0.040 |
Why?
|
Edema | 1 | 2023 | 760 | 0.040 |
Why?
|
RNA Interference | 2 | 2018 | 2828 | 0.040 |
Why?
|
Muscle Cells | 1 | 2019 | 194 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18061 | 0.040 |
Why?
|
Stem Cell Niche | 1 | 2022 | 347 | 0.040 |
Why?
|
Translocation, Genetic | 1 | 2024 | 1393 | 0.040 |
Why?
|
Receptors, Leptin | 1 | 2019 | 355 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4642 | 0.040 |
Why?
|
E2F1 Transcription Factor | 1 | 2018 | 183 | 0.040 |
Why?
|
Cell Movement | 2 | 2023 | 5192 | 0.040 |
Why?
|
Aged | 4 | 2024 | 171050 | 0.040 |
Why?
|
Epidermal Growth Factor | 1 | 2020 | 698 | 0.030 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2021 | 727 | 0.030 |
Why?
|
Macrophages, Alveolar | 1 | 2019 | 413 | 0.030 |
Why?
|
DNA Methylation | 1 | 2011 | 4425 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5019 | 0.030 |
Why?
|
Keratins | 1 | 2018 | 497 | 0.030 |
Why?
|
Connexin 43 | 1 | 2017 | 202 | 0.030 |
Why?
|
Germ-Line Mutation | 1 | 2024 | 1883 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2023 | 1622 | 0.030 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2017 | 220 | 0.030 |
Why?
|
Gene Deletion | 1 | 2023 | 2666 | 0.030 |
Why?
|
Cell Count | 1 | 2019 | 1823 | 0.030 |
Why?
|
Transcription Factors | 1 | 2015 | 12123 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2024 | 1888 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12800 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16041 | 0.030 |
Why?
|
Gene Library | 1 | 2018 | 1066 | 0.030 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2045 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 578 | 0.030 |
Why?
|
Open Reading Frames | 1 | 2018 | 820 | 0.030 |
Why?
|
Child, Preschool | 1 | 2017 | 42468 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2019 | 2477 | 0.030 |
Why?
|
Drug Delivery Systems | 2 | 2019 | 2207 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2017 | 720 | 0.030 |
Why?
|
Cytoplasmic Granules | 1 | 2017 | 574 | 0.030 |
Why?
|
RNA, Neoplasm | 1 | 2017 | 745 | 0.030 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2020 | 1118 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2019 | 15648 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2017 | 962 | 0.030 |
Why?
|
Cells, Cultured | 2 | 2022 | 18972 | 0.030 |
Why?
|
Mitral Valve Insufficiency | 1 | 2023 | 1414 | 0.030 |
Why?
|
Cell Growth Processes | 1 | 2014 | 380 | 0.030 |
Why?
|
Fatty Acids | 1 | 2021 | 1806 | 0.030 |
Why?
|
Adult | 3 | 2018 | 222974 | 0.030 |
Why?
|
Apoptosis | 3 | 2015 | 9511 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 752 | 0.030 |
Why?
|
Middle Aged | 5 | 2024 | 222903 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1183 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2015 | 2546 | 0.020 |
Why?
|
Oncogenes | 1 | 2018 | 1232 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2015 | 1746 | 0.020 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 11888 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2024 | 3683 | 0.020 |
Why?
|
Polymers | 1 | 2019 | 1621 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2021 | 3229 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2012 | 11865 | 0.020 |
Why?
|
Leukocytes | 1 | 2019 | 2027 | 0.020 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 741 | 0.020 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2012 | 305 | 0.020 |
Why?
|
Liver | 1 | 2007 | 7559 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2017 | 5336 | 0.020 |
Why?
|
Male | 8 | 2024 | 363585 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2019 | 1747 | 0.020 |
Why?
|
Ischemia | 1 | 2019 | 1910 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2427 | 0.020 |
Why?
|
Hypertension | 2 | 2021 | 8626 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2018 | 4618 | 0.020 |
Why?
|
Paclitaxel | 1 | 2017 | 1728 | 0.020 |
Why?
|
Collagen Type I | 1 | 2012 | 616 | 0.020 |
Why?
|
Child | 1 | 2017 | 80499 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1352 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2017 | 1998 | 0.020 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2012 | 679 | 0.020 |
Why?
|
B-Lymphocytes | 1 | 2022 | 4779 | 0.020 |
Why?
|
Models, Animal | 1 | 2015 | 2120 | 0.020 |
Why?
|
Tissue Distribution | 1 | 2012 | 2266 | 0.020 |
Why?
|
Myocytes, Cardiac | 1 | 2017 | 1670 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1876 | 0.020 |
Why?
|
Pneumonia | 1 | 2019 | 2156 | 0.020 |
Why?
|
Signal Transduction | 3 | 2020 | 23589 | 0.020 |
Why?
|
Adipose Tissue | 1 | 2019 | 3313 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4850 | 0.020 |
Why?
|
Fibroblasts | 1 | 2018 | 4161 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2019 | 3563 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1059 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6832 | 0.020 |
Why?
|
Genotype | 1 | 2021 | 13024 | 0.020 |
Why?
|
CpG Islands | 1 | 2011 | 1207 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3336 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2470 | 0.020 |
Why?
|
Sleep | 1 | 2022 | 4824 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1884 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2017 | 2896 | 0.020 |
Why?
|
Chromosomes, Mammalian | 1 | 2007 | 147 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6252 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1376 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2015 | 2968 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2790 | 0.010 |
Why?
|
Stroke Volume | 1 | 2018 | 5596 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2630 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9647 | 0.010 |
Why?
|
Exercise | 1 | 2019 | 5937 | 0.010 |
Why?
|
Antibodies, Neutralizing | 1 | 2012 | 2010 | 0.010 |
Why?
|
Ovarian Neoplasms | 1 | 2019 | 4900 | 0.010 |
Why?
|
Genomics | 1 | 2018 | 5924 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2017 | 12769 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7584 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5693 | 0.010 |
Why?
|
Piperazines | 1 | 2011 | 2546 | 0.010 |
Why?
|
Pyrimidines | 1 | 2011 | 3044 | 0.010 |
Why?
|
Phenotype | 1 | 2014 | 16706 | 0.010 |
Why?
|
Heart Failure | 1 | 2018 | 11840 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2007 | 7599 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2012 | 65180 | 0.000 |
Why?
|
Concepts
(238)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(111)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_